Lv51
910 积分 2025-11-18 加入
Targeting the STAT3 pathway with STAT3 degraders
5天前
已完结
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
25天前
已完结
Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes. Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes
1个月前
已完结
Effects of administration of an anti-cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studies
2个月前
已完结
A pilot study of anti-CD5 ricin A chain immunoconjugate in systemic lupus erythematosus
2个月前
已关闭
Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024)
2个月前
已完结
STAT3 degraders inhibit cellular activation, cytokine production, and Th17 development, resulting in inhibition of autoimmunity in the MOG-EAE model of CNS inflammation
2个月前
已关闭
OP0080 STAT3 DEGRADERS INHIBIT Th17 DEVELOPMENT AND CYTOKINE PRODUCTION RESULTING IN PROFOUND INHIBITION OF COLLAGEN-INDUCED AUTOIMMUNE MURINE ARTHRITIS
2个月前
已完结
Selective inhibition of STAT3 transcriptional activity by novel small molecules alleviates the development of lupus in mice
2个月前
已完结
Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3
2个月前
已完结
皖公网安备34019202002308
